STAMFORD, Conn., March 16, 2017 -- Finacity Corporation (“Finacity”) announced that it has successfully launched a future flow receivables securitization for Compañía Minera Autlán, S.A.B. de C.V. (BMV:AUTLANB) (“AUTLAN”). The transaction is publicly listed on the Mexican Stock Exchange (“AUTLNCB 17”) and it includes an unconditional and irrevocable partial guarantee of 33% from Banco de Comercio Exterior, S.N.C. (“Bancomext”) in addition to a credit insurance policy from Atradius Seguros de Crédito, S.A. (“Atradius”). The transaction size is MXN$1.43 billion with a 5 year tenor and it has been assigned a local HRAA- rating by HR Ratings de México, S.A. de C.V. and AA/M rating by Verum, Calificadora de Valores, S.A.P.I. de C.V. Finacity acted as structuring agent and is responsible for ongoing program administration and reporting.
About Autlán
AUTLAN (www.autlan.com.mx) (BMV:AUTLANB) was founded in 1953 and is the only producer of manganese ferroalloys and manganese ore in Mexico while also being the largest and only integrated producer in North America. AUTLAN is based in Monterrey, Mexico and has 3 ferroalloys plants and 3 mines throughout the country and exports its products to more than 20 countries. In addition to its Ferroalloy and Mining Divisions, AUTLAN has an Energy Division that produces electricity via a hydroelectric power plant.
About Finacity
Finacity specializes in the structuring and provision of efficient capital markets receivables funding programs, supplier and payables finance, back-up servicing, and bond administration. Finacity currently facilitates the financing and administration of an annual receivables volume of approximately US $100 billion. With resources in the USA, Europe and Latin America, Finacity conducts business throughout the world with obligors in approximately 175 countries. For further information, please visit www.finacity.com.
For more information on this transaction, please contact: Finacity Antonio Villa US Tel +1 203 428 3510, [email protected]


Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs 



